Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPI1 | P60174 | 2/20 | 0.50 |
| ▸ | PGK1 | P00558 | 1/20 | 0.43 |
| ▸ | PGK2 | P07205 | 1/20 | 0.43 |
| ▸ | PEPD | P12955 | 1/20 | 0.42 |
| ▸ | PGD | P52209 | 2/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Ketoglutaric Acid SCHEMBL2030659 | 0.87 | EGLN1 (0.56) | TPI1PGK1PGK2PEPDPGD | |
| Phosphoglycolic Acid SCHEMBL20798069 | 0.78 | TPI1 (0.54) | TPI1PGK1PGK2PGDLPAR1 | |
| Phosphoglycolic Acid SCHEMBL380471 | 0.78 | — | — | |
| Glutamic Acid SCHEMBL345401 | 0.77 | GRM8 (0.56) | — | |
| SCHEMBL21197357 | 0.77 | TPI1 (0.48) | TPI1PGK1PGK2PGDLPAR1 | |
| SCHEMBL2030661 | 0.77 | TPI1 (0.36) | TPI1PGK1PGK2PEPDPGD | |
| Phosphoglycolic Acid SCHEMBL5586781 | 0.76 | TPI1 (0.52) | TPI1PGK1PGK2PGDLPAR1 | |
| Phosphoglycolic Acid SCHEMBL29156120 | 0.76 | TPI1 (0.52) | TPI1PGK1PGK2PGD | |
| SCHEMBL6150390 | 0.75 | TPI1 (0.46) | TPI1PGK1PGK2PEPDPGD | |
| SCHEMBL5485133 | 0.75 | TPI1 (0.56) | TPI1PGK1PGK2PGDLPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 801 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4605521-A2 | GENETICALLY MODIFIED HOST CELLS PRODUCING L-SERINE | CysBio ApS (DK) | 2025-08-27 | — | — | EP | claimed |
| US-20250215468-A1 | METHOD FOR CONVERTING CARBON SOURCE INTO SERINE | NAN YA PLASTICS CORPORATION (TW) | 2025-07-03 | — | — | US | claimed |
| WO-2025104134-A9 | EXPRESSION OF BIOMOLECULES WITH IMPROVED PROMOTER AND TIR | CYSBIO APS (DK) | 2025-06-19 | — | — | WO | claimed |
| WO-2025104134-A2 | EXPRESSION OF BIOMOLECULES WITH IMPROVED PROMOTER AND TIR | CYSBIO APS (DK) | 2025-05-22 | — | — | WO | claimed |
| EP-4556561-A1 | EXPRESSION OF BIOMOLECULES WITH IMPROVED PROMOTER AND TIR | CysBio ApS (DK) | 2025-05-21 | — | — | EP | claimed |
| CN-120005781-A | Expression of biomolecules with improved promoters and TIR | 赛斯生物私人有限公司 | 2025-05-16 | — | — | CN | claimed |
| US-20240385183-A1 | METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS | NORTHWESTERN UNIVERSITY | 2024-11-21 | — | — | US | claimed |
| EP-4381076-A1 | MICROORGANISMS AND METHODS FOR IMPROVED BIOLOGICAL PRODUCTION OF ETHYLENE GLYCOL | Lanzatech, Inc. (US) | 2024-06-12 | — | — | EP | claimed |
| WO-2024084049-A2 | GENETICALLY MODIFIED HOST CELLS PRODUCING L-SERINE | CYSBIO APS (DK) | 2024-04-25 | — | — | WO | claimed |
| US-11952607-B2 | Microorganisms and methods for improved biological production of ethylene glycol | LANZATECH, INC. (US) | 2024-04-09 | — | — | US | claimed |
| EP-0599819-B1 | Use of hydroxycarboxylic acids and derivatives for the preparation of topical dermatologic compositions for the treatment of wrinkles | SCOTT EUGENE J VAN (US) | 1997-04-02 | — | — | EP | claimed |
| US-5561158-A | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | TRISTRATA, INCORPORATED | 1996-10-01 | — | — | US | claimed |
| US-5561157-A | INCLUDES ORGANIC ALPHA AND BETA HYDROXY OR KETO CARBOXYLIC ACIDS, ESTERS, LACTONES AND/OR SALTS; USED FOR SKIN DISORDERS | TRISTRATA INC (US) | 1996-10-01 | — | — | US | claimed |
| US-5554654-A | COMPRISING SALICYLIC ACID, RETINOIC ACID, ERYTHROMYCIN, METRONIDAZOLE, TETRACYCLINE, CLINDAMYCIN, MINOCYCLINE, MECLOCYCLINE OR BENZILIC ACID BY COMBINING WITH 2-HYDROXY ACID, 2-KETOACID, DERIVATIVE THEREOF OR RELATED COMPOUND | TRISTRATA INC (US) | 1996-09-10 | — | — | US | claimed |
| US-5554597-A | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | TRISTRATA INC (US) | 1996-09-10 | — | — | US | claimed |
| US-5554652-A | TOPICALLY APPLYING MIXTURE TO REDUCE OR PREVENT SKIN DISORDERS | TRISTRATA INC (US) | 1996-09-10 | — | — | US | claimed |
| EP-0273202-B1 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | SCOTT EUGENE J VAN (US) | 1995-06-21 | — | — | EP | claimed |
| EP-0599819-A2 | Additives enhancing topical actions of therapeutic agents | Van Scott, Eugene J., Dr. (US) | 1994-06-01 | — | — | EP | claimed |
| EP-0273202-A2 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | Van Scott, Eugene J., Dr. (US) | 1988-07-06 | — | — | EP | claimed |
| US-4380549-A | ONE OR MORE HYDROXYCARBOXYLIC ACIDS | SCOTT EUGENE J VAN | 1983-04-19 | — | — | US | claimed |